Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway

Tamoxifen is a successful endocrine therapy drug for estrogen receptor–positive (ER+) breast cancer. However, resistance to tamoxifen compromises the efficacy of endocrine treatment. In the present study, we identified potential tamoxifen resistance–related gene markers and investigated their mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yijie, Wang, Zhu, Luo, Chuanxu, Wang, Yu, Wang, Yanping, Zhong, Xiaorong, Zheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948370/
https://www.ncbi.nlm.nih.gov/pubmed/31911277
http://dx.doi.org/10.1016/j.tranon.2019.12.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948370/
https://www.ncbi.nlm.nih.gov/pubmed/31911277
http://dx.doi.org/10.1016/j.tranon.2019.12.005

Ejemplares similares